SinoMab forms HK$12m research partnership with university
SinoMab BioScience has entered a three-year strategic cooperation agreement with Sun Yat-sen University Institute of Advanced Studies Hong Kong, running from August 2025 to August 2028.
The partnership focuses on joint research and development in biomedicine, leveraging mutual expertise for drug discovery and clinical development.
SinoMab will provide HK$1m quarterly funding, with HK$1m annually going to the University of Oxford to facilitate joint research innovation and clinical translation efforts.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when SinoMab BioScience publishes news
Free account required • Unsubscribe anytime